Wed, April 24, 2013
Tue, April 23, 2013
Mon, April 22, 2013
Fri, April 19, 2013
Thu, April 18, 2013
Wed, April 17, 2013

Matthew Harrison Maintained (VRTX) at Hold with Increased Target to $91 on, Apr 22nd, 2013


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-91-on-apr-22nd-2013.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Increased Target from $45 to $91 on, Apr 22nd, 2013.

Matthew has made no other calls on VRTX in the last 4 months.



There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Debjit Chattopadhyay of "Janney Montgomery Scott" Initiated at Strong Buy and Held Target at $54 on, Wednesday, January 2nd, 2013

Publication Contributing Sources